Marijuana Stocks: Is the Bottom Near After 2019 Selloff?

Here is why it’s still not the right time to buy marijuana stocks, such as Aurora Cannabis Inc.(TSX:ACB)(NYSE:ACB), even after a major correction of 2019.

question marks written reminders tickets

Image source: Getty Images

After an eight-month rout that wiped out almost two-thirds of their market value, marijuana stocks have become a no-go area for many investors.

The slump has been so quick and deep that it has made it tough to call a bottom after the bubble burst.

One of the major reasons that crushed marijuana stocks this year was producers’ inability to correctly foresee the execution risks that almost hit all major producers after Canada allowed the recreational use of marijuana a year ago.

During that time, I warned our readers many times of those risks and cautioned against overly aggressive investing approach in pot stocks.

As the year went by, many investors realised that it wouldn’t be easy for these companies to become profitable without clear visibility on the demand-supply situation and when the government regulations are still evolving.

In addition, earnings disappointments by some of the largest producers, including Canopy Growth Corp. (TSX:WEED)(NYSE:CGC), Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) and Cronos Group Inc. (TSX:CRON)(NASDAQ:CRON), made the situation worst. These producers also failed to communicate to the market about their future growth path. 

In the latest earnings report, Aurora Cannabis said it will still reach profitability before “any of its peers,” but Chairman Michael Singer didn’t say exactly when that will happen. The news sent its stock plunging by more than 18% that day.

Earlier, Canopy’s Chief Executive Officer Mark Zekulin said the company is still on track to achieve its targets, including positive adjusted earnings before interest, taxes, depreciation and amortization in Canada by fiscal 2021 and full profitability in three to five years.

Its expectation for gross margins above 40% by the end of the current fiscal year is “under pressure” but still “achievable,” Zekulin said in an interview with Bloomberg.

Funding freeze for marijuana stocks

The final shock that broke the camel’s back came when financial markets stopped providing funding to these companies.

As long as the capital markets remain closed, some bankruptcies are inevitable, Cowen & Co. analyst Vivien Azer said last week in a Bloomberg article last week.

“I think over time having a shakeout and seeing some companies go bankrupt is going to be very helpful to the industry,” Azer said. “In the near term that’s probably another leg down but ultimately that’s what gets us to the positive catalyst. We need to see the marketplace get cleaned up.”

After this painful year for marijuana stocks, I see a buying opportunity only in the big names, such as Canopy.

The company is unlikely to see the kind of financial difficulties that smaller and mid-cap producers are facing due to its strong ties with an alcohol giant Constellation Brands, which holds about 36% of stake and a majority of its board seats.

At this stage of correction, I don’t think it’s a good strategy to buy mid-cap and smaller producers, such as Aurora Cannabis.

These producers will continue to struggle and may have to close their shops if the funding markets don’t reopen for them.

Bottom line

After a drastic correction in marijuana stocks in 2019, I don’t see a major rebound in their stock values next year.

Only big producers, such as Canopy, can sustain this extreme bearish phase and could emerge unscathed because of their leading position and their partnership with the deep-pocketed backers. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Haris Anwar has no position in the stocks mentioned in this article.

More on Cannabis Stocks

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

A close up image of Canadian $20 Dollar bills
Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »

Marijuana plant and cannabis oil bottles isolated
Energy Stocks

3 Canadian Value Stocks to Buy Right Now

Undervalued Canadian stocks such as Secure Energy should be part of your shopping list in May 2024.

Read more »